It Takes Two to Tangle: Microneedle Patches Co‐delivering Monoclonal Antibodies and Engineered Antimicrobial Peptides Effectively Eradicate Wound Biofilms
Macromolecular Bioscience · 2024-05 · 24 (5)
DOI: 10.1002/mabi.202300519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 20.01.2024. Verfasst von Yajuan Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, College of Medicine, University of Nebraska Medical Center, O…. Hauptthemen laut MEDLINE: Biofilms, Antibodies, Monoclonal, Needles, Antimicrobial Peptides. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, University of Nebraska Medical Center, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Wound biofilms pose a great clinical challenge. Herein, this work reports a dissolvable microneedle patch for dual delivery of monoclonal antibodies anti‐PBP2a and engineers antimicrobial peptides W379. In vitro antibacterial efficacy testing with microneedle patches containing a combination of 250 ng mL −1 W379 and 250 ng mL −1 anti‐BPB2a decreases the bacterial count from ≈3.31 × 10 7 CFU mL −1 to 1.28 × 10 2 CFU mL −1 within 2 h without eliciting evident cytotoxicity. Ex vivo testing indicates W379 and anti‐PBP2a co‐loaded microneedle patch displayed a remarkable reduction of bacterial load by ≈7.18 log CFU after administered only once within 48 h. The bacterial count is significantly diminished compared to the treatment by either W379 or anti‐PBP2a‐loaded alone microneedle patches. When administered twice within 48 h, no bacteria are identified. Further in vivo study also reveals that after two treatments of W379 and anti‐PBP2a co‐loaded PVP microneedle patches within 48 h, the bacterial colonies are undetectable in a type II diabetic mouse wound biofilm model. Taken together, W379 and anti‐PBP2a co‐loaded PVP microneedle patches hold great promise in treating wound biofilms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
- Department of Surgery-Plastic Surgery, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
- Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
- Department of Mechanical and Materials Engineering, College of Engineering, University of Nebraska Lincoln, Lincoln, NE, 68588, USA.
ORCID-Profile: Jingwei Xie
Förderung
- NIGMS NIH HHS
- University of Nebraska Medical Center
- National Institute of General Medical Sciences
Zitieren
APA
Su, Y., Shahriar, S. S. M., Andrabi, S. M., Wang, C., Sharma, N. S., Xiao, Y., Wong, S. L., Wang, G., & Xie, J. (2024). It Takes Two to Tangle: Microneedle Patches Co‐delivering Monoclonal Antibodies and Engineered Antimicrobial Peptides Effectively Eradicate Wound Biofilms. Macromolecular Bioscience, 24(5). https://doi.org/10.1002/mabi.202300519
Vancouver
Su Y, Shahriar SSM, Andrabi SM, Wang C, Sharma NS, Xiao Y, et al. It Takes Two to Tangle: Microneedle Patches Co‐delivering Monoclonal Antibodies and Engineered Antimicrobial Peptides Effectively Eradicate Wound Biofilms. Macromolecular Bioscience. 2024;24(5). doi:10.1002/mabi.202300519
BibTeX
@article{Su2024,
author = {Su, Yajuan and Shahriar, Shatil S M and Andrabi, Syed Muntazir and Wang, Chenlong and Sharma, Navatha Shree and Xiao, Yizhu and Wong, Shannon L and Wang, Guangshun and Xie, Jingwei},
title = {It Takes Two to Tangle: Microneedle Patches Co‐delivering Monoclonal Antibodies and Engineered Antimicrobial Peptides Effectively Eradicate Wound Biofilms},
journal = {Macromolecular Bioscience},
year = {2024},
volume = {24},
number = {5},
doi = {10.1002/mabi.202300519}
}
EUVIMED